If you need more lookups,
subscriptions start at $34 USD/month.
Eric Venker Location
New York, NY, US
Eric Venker Work
2025 -now Chief Executive Officer @
2020 -now Board Member @
2018 -now President and Chief Operating Officer @
2017 -2018 Chief of Staff to the CEO @
2014 -2017 Analyst @
2021 -now Board Member @
2022 -2024 Board Member @ Telavant (Acquired by Roche for $7.25B)
2020 -2022 Board Member @
2015 -2017 Internal Medicine Resident @
2013 -2017 Founder and CEO @
2011 -2015 Clinical Pharmacist @
Eric Venker Education
Yale University School of Medicine
MD
St. Louis College of Pharmacy
PharmD
Eric Venker Skills
Clinical Research
Hospitals
Research
Healthcare
Pharmacology
Medicine
Diabetes
Medical Education
Public Speaking
Public Health
Pharmacists
Pharmaceutical Industry
Pharmacy
Patient Safety
PowerPoint
Data Analysis
Microsoft Excel
Microsoft Word
Social Media
Lifesciences
Healthcare Management
Teaching
Leadership
Microsoft Office
Pharmacy Automation
Startups
Eric Venker Summary
Eric Venker, based in New York, NY, US, is currently a Chief Executive Officer at Immunovant. Eric Venker brings experience from previous roles at Immunovant and Roivant Sciences. Eric Venker holds a MD @ Yale University School of Medicine. With a robust skill set that includes Clinical Research, Hospitals, Research, Healthcare, Pharmacology and more. Eric Venker has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Eric Venker?
Find contact details for 700 million professionals.